Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-22

FDA Approved: ARISTADA INITIO — Supplemental Application (Alkermes, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for ARISTADA INITIO, providing a loading-dose formulation of aripiprazole lauroxil for initiating treatment of schiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ARISTADA INITIO (ARIPIPRAZOLE LAUROXIL)

Snippet

SUPPL AP for ARISTADA INITIO (ARIPIPRAZOLE LAUROXIL)